Citadel Advisors
MESO

Citadel Advisors’s Mesoblast MESO Stock Holding History

Citadel Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-85,959
Closed -$1.28M – 14407
2026
Q1 		$1.32M Sell
85,959
-45,429
-35% -$756K ﹤0.01% 7027
2025
Q4 		$2.37M Buy
+131,388
New +$2.26M ﹤0.01% 5597
2025
Q3 		– Sell
-74,636
Closed -$1.09M – 13571
2025
Q2 		$813K Sell
74,636
-412,157
-85% -$4.62M ﹤0.01% 7542
2025
Q1 		$6.08M Buy
+486,793
New +$8.02M ﹤0.01% 3569
2024
Q4 		– Sell
-39,968
Closed -$443K – 15042
2024
Q3 		$327K Sell
39,968
-37,326
-48% -$253K ﹤0.01% 9154
2024
Q2 		$526K Buy
+77,294
New +$528K ﹤0.01% 7945
2024
Q1 		– Sell
-2,669
Closed -$5.68K – 15133
2023
Q4 		$5.87K Buy
+2,669
New +$6.36K ﹤0.01% 13395
2023
Q3 		– Sell
-28,143
Closed -$135K – 14771
2023
Q2 		$220K Sell
28,143
-390
-1% -$2.79K ﹤0.01% 9677
2023
Q1 		$188K Sell
28,533
-40,233
-59% -$266K ﹤0.01% 10290
2022
Q4 		$400K Buy
+68,766
New +$430K ﹤0.01% 8715
2022
Q1 		– Sell
-20,799
Closed -$177K – 14190
2021
Q4 		$200K Sell
20,799
-4,070
-16% -$47.3K ﹤0.01% 11853
2021
Q3 		$299K Buy
24,869
+3,032
+14% +$42.1K ﹤0.01% 11070
2021
Q2 		$327K Buy
21,837
+3,385
+18% +$53.1K ﹤0.01% 11054
2021
Q1 		$305K Buy
+18,452
New +$349K ﹤0.01% 10819
2020
Q4 		– Sell
-22,736
Closed -$560K – 11271
2020
Q3 		$844K Buy
22,736
+4,644
+26% +$146K ﹤0.01% 6340
2020
Q2 		$412K Buy
18,092
+9,152
+102% +$196K ﹤0.01% 7412
2020
Q1 		$78K Buy
+8,940
New +$137K ﹤0.01% 8801
2019
Q4 		– Sell
-5,856
Closed -$81K – 9488
2019
Q3 		$81K Buy
+5,856
New +$64.5K ﹤0.01% 8568
2018
Q4 		– Sell
-13,151
Closed -$215K – 9511
2018
Q3 		$215K Buy
+13,151
New +$167K ﹤0.01% 8110

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

Citadel Advisors's MESO Position: Q2 2026 in Review

Citadel Advisors sold out of Mesoblast (MESO) in Q2 2026, closing a stake of 85,959 shares — an estimated $1.28M sold.

Citadel Advisors first reported a position in MESO in Q3 2018 and held it in 19 quarters. The position peaked at $6.08M in Q1 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Citadel Advisors reported no remaining Mesoblast position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 85,959 Mesoblast shares in Q2 2026, an estimated $1.28M.
  • Citadel Advisors first reported a position in Mesoblast in Q3 2018 and held it in 19 quarters.
  • Citadel Advisors's Mesoblast position peaked at $6.08M in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.